InterCure (NASDAQ:INCR) vs. CompuMed (OTCMKTS:CMPD) Critical Comparison

CompuMed (OTCMKTS:CMPD) and InterCure (NASDAQ:INCR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Institutional & Insider Ownership

8.3% of InterCure shares are owned by institutional investors. 22.0% of CompuMed shares are owned by insiders. Comparatively, 0.2% of InterCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares CompuMed and InterCure”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CompuMed	$7.55 million	0.78	-$60,000.00	($0.05)	-88.00
InterCure	$243.12 million	0.17	-$18.32 million	$0.08	11.54

CompuMed has higher earnings, but lower revenue than InterCure. CompuMed is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for CompuMed and InterCure, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CompuMed	0	0	0	0	0.00
InterCure	1	0	0	0	1.00

Volatility & Risk

CompuMed has a beta of -0.35, suggesting that its share price is 135% less volatile than the S&P 500. Comparatively, InterCure has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500.

Profitability

This table compares CompuMed and InterCure’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CompuMed	-0.85%	-1.90%	-1.29%
InterCure	N/A	N/A	N/A

Summary

InterCure beats CompuMed on 9 of the 12 factors compared between the two stocks.

About CompuMed

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.